Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

FDA Approval Summary: Atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1.

Narayan P, Wahby S, Gao JJ, Amiri-Kordestani L, Ibrahim A, Bloomquist E, Tang S, Xu Y, Liu J, Fu W, Song P, King-Kallimanis BL, Hou S, Gong Y, Kalavar S, Ghosh S, Philip R, Goldberg KB, Theoret MR, Blumenthal GM, Kluetz PG, Sridhara R, Pazdur R, Beaver JA.

Clin Cancer Res. 2020 Jan 30. pii: clincanres.3545.2019. doi: 10.1158/1078-0432.CCR-19-3545. [Epub ahead of print]

PMID:
32001481
2.

US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017.

Fiero MH, Roydhouse JK, Vallejo J, King-Kallimanis BL, Kluetz PG, Sridhara R.

Lancet Oncol. 2019 Oct;20(10):e582-e589. doi: 10.1016/S1470-2045(19)30335-3. Epub 2019 Sep 30. Review.

PMID:
31579004
3.

Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled Analysis.

Howie LJ, Singh H, Bloomquist E, Wedam S, Amiri-Kordestani L, Tang S, Sridhara R, Sanchez J, Prowell TM, Kluetz PG, King-Kallimanis BL, Gao JJ, Ibrahim A, Goldberg KB, Theoret M, Pazdur R, Beaver JA.

J Clin Oncol. 2019 Dec 20;37(36):3475-3483. doi: 10.1200/JCO.18.02217. Epub 2019 Sep 27.

PMID:
31560580
4.

Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions.

King-Kallimanis BL, Howie LJ, Roydhouse JK, Singh H, Theoret MR, Blumenthal GM, Kluetz PG.

Clin Trials. 2019 Jun;16(3):322-326. doi: 10.1177/1740774519836991. Epub 2019 Mar 18.

PMID:
30880446
5.

Blinding and Patient-Reported Outcome Completion Rates in US Food and Drug Administration Cancer Trial Submissions, 2007-2017.

Roydhouse JK, King-Kallimanis BL, Howie LJ, Singh H, Kluetz PG.

J Natl Cancer Inst. 2019 May 1;111(5):459-464. doi: 10.1093/jnci/djy181.

PMID:
30561711
6.

FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast Cancer.

Howie LJ, Scher NS, Amiri-Kordestani L, Zhang L, King-Kallimanis BL, Choudhry Y, Schroeder J, Goldberg KB, Kluetz PG, Ibrahim A, Sridhara R, Blumenthal GM, Pazdur R, Beaver JA.

Clin Cancer Res. 2019 May 15;25(10):2949-2955. doi: 10.1158/1078-0432.CCR-18-3003. Epub 2018 Dec 14.

PMID:
30552112
7.

Age-related differences in patient-reported outcomes in patients with advanced lung cancer receiving anti-PD-1/PD-L1 therapy.

King-Kallimanis BL, Kanapuru B, Blumenthal GM, Theoret MR, Kluetz PG.

Semin Oncol. 2018 Aug;45(4):201-209. doi: 10.1053/j.seminoncol.2018.06.003. Epub 2018 Oct 25. Review.

PMID:
30482633
8.

Learning from Patients: Reflections on Use of Patient-Reported Outcomes in Lung Cancer Trials.

Basu Roy U, King-Kallimanis BL, Kluetz PG, Selig W, Ferris A.

J Thorac Oncol. 2018 Dec;13(12):1815-1817. doi: 10.1016/j.jtho.2018.09.003. Epub 2018 Oct 15. No abstract available.

9.

Patient-reported treatment-related symptom burden for patients with advanced melanoma in Canada.

Cheung WY, White MK, Bayliss MS, Stroupe A, Lovley A, King-Kallimanis BL, Lasch K.

Support Care Cancer. 2019 Jan;27(1):219-227. doi: 10.1007/s00520-018-4316-9. Epub 2018 Jun 23.

10.

Humanistic burden of disease for patients with advanced melanoma in Canada.

Cheung WY, Bayliss MS, White MK, Stroupe A, Lovley A, King-Kallimanis BL, Lasch K.

Support Care Cancer. 2018 Jun;26(6):1985-1991. doi: 10.1007/s00520-017-4025-9. Epub 2018 Jan 10.

11.

Falls, non-accidental falls and syncope in community-dwelling adults aged 50 years and older: Implications for cardiovascular assessment.

Bhangu J, King-Kallimanis BL, Donoghue OA, Carroll L, Kenny RA.

PLoS One. 2017 Jul 21;12(7):e0180997. doi: 10.1371/journal.pone.0180997. eCollection 2017.

12.

Trajectories of depressive symptoms in community-dwelling older adults: A six-month longitudinal study with monthly assessment.

Fishleder S, Gum AM, King-Kallimanis BL, Schonfeld L.

J Affect Disord. 2016 Jul 1;198:171-7. doi: 10.1016/j.jad.2016.02.058. Epub 2016 Mar 10.

PMID:
27017373
13.

Negative perceptions of aging predict longitudinal decline in cognitive function.

Robertson DA, King-Kallimanis BL, Kenny RA.

Psychol Aging. 2016 Feb;31(1):71-81. doi: 10.1037/pag0000061. Epub 2015 Dec 21.

PMID:
26691302
14.

Strengths and Limitations of the MoCA for Assessing Cognitive Functioning: Findings From a Large Representative Sample of Irish Older Adults.

Coen RF, Robertson DA, Kenny RA, King-Kallimanis BL.

J Geriatr Psychiatry Neurol. 2016 Jan;29(1):18-24. doi: 10.1177/0891988715598236. Epub 2015 Aug 6.

PMID:
26251108
15.

Negative perceptions of aging and decline in walking speed: a self-fulfilling prophecy.

Robertson DA, Savva GM, King-Kallimanis BL, Kenny RA.

PLoS One. 2015 Apr 29;10(4):e0123260. doi: 10.1371/journal.pone.0123260. eCollection 2015.

16.

Measuring frailty using self-report and test-based health measures.

Theou O, O'Connell MD, King-Kallimanis BL, O'Halloran AM, Rockwood K, Kenny RA.

Age Ageing. 2015 May;44(3):471-7. doi: 10.1093/ageing/afv010. Epub 2015 Feb 16.

17.

CASP-19 special section: how does chronic disease status affect CASP quality of life at older ages? Examining the WHO ICF disability domains as mediators of this relationship.

Sexton E, King-Kallimanis BL, Layte R, Hickey A.

Aging Ment Health. 2015 Jul;19(7):622-33. doi: 10.1080/13607863.2014.955457. Epub 2014 Sep 11.

PMID:
25209970
18.

Factor structure for the frailty syndrome was consistent across Europe.

King-Kallimanis BL, Kenny RA, Savva GM.

J Clin Epidemiol. 2014 Sep;67(9):1008-15. doi: 10.1016/j.jclinepi.2014.05.002. Epub 2014 Jun 16.

PMID:
24948043
19.

Development of the brief ageing perceptions questionnaire (B-APQ): a confirmatory factor analysis approach to item reduction.

Sexton E, King-Kallimanis BL, Morgan K, McGee H.

BMC Geriatr. 2014 Apr 9;14:44. doi: 10.1186/1471-2318-14-44.

20.

Psychometric evaluation of the CASP-19 quality of life scale in an older Irish cohort.

Sexton E, King-Kallimanis BL, Conroy RM, Hickey A.

Qual Life Res. 2013 Nov;22(9):2549-59. doi: 10.1007/s11136-013-0388-7. Epub 2013 Mar 16.

PMID:
23504522
21.

Epidemiology of syncope/collapse in younger and older Western patient populations.

Kenny RA, Bhangu J, King-Kallimanis BL.

Prog Cardiovasc Dis. 2013 Jan-Feb;55(4):357-63. doi: 10.1016/j.pcad.2012.11.006. Review.

PMID:
23472771
22.

Measurement bias of the SF-36 Health Survey in older adults with chronic conditions.

Meng H, King-Kallimanis BL, Gum A, Wamsley B.

Qual Life Res. 2013 Nov;22(9):2359-69. doi: 10.1007/s11136-013-0373-1. Epub 2013 Mar 6.

PMID:
23463018
23.

Testing the Assumption of Measurement Invariance in the SAMHSA Mental Health and Alcohol Abuse Stigma Assessment in Older Adults.

King-Kallimanis BL, Oort FJ, Lynn N, Schonfeld L.

Ageing Int. 2012 Dec;37(4):441-458. Epub 2011 Jul 30.

24.

Six-month longitudinal patterns of mental health treatment utilization by older adults with depressive symptoms.

Gum AM, Iser L, King-Kallimanis BL, Petkus A, DeMuth A, Schonfeld L.

Psychiatr Serv. 2011 Nov;62(11):1353-60. doi: 10.1176/ps.62.11.pss6211_1353.

25.

Assessing measurement invariance of a health-related quality-of-life questionnaire in radiotherapy patients.

King-Kallimanis BL, ter Hoeven CL, de Haes HC, Smets EM, Koning CC, Oort FJ.

Qual Life Res. 2012 Dec;21(10):1745-53. doi: 10.1007/s11136-011-0094-2. Epub 2011 Dec 23.

26.

Using structural equation modeling to detect response shift in performance and health-related quality of life scores of multiple sclerosis patients.

King-Kallimanis BL, Oort FJ, Nolte S, Schwartz CE, Sprangers MA.

Qual Life Res. 2011 Dec;20(10):1527-40. doi: 10.1007/s11136-010-9844-9. Epub 2011 Jan 19. Erratum in: Qual Life Res. 2011 Dec;20(10):1541.

27.

Evaluation of the impact of implementation of a Medical Assessment and Planning Unit on length of stay.

Brand CA, Kennedy MP, King-Kallimanis BL, Williams G, Bain CA, Russell DM.

Aust Health Rev. 2010 Aug;34(3):334-9. doi: 10.1071/AH09798.

PMID:
20797367
28.

Trading years for perfect health: results from the health and retirement study.

Ayalon L, King-Kallimanis BL.

J Aging Health. 2010 Dec;22(8):1184-97. doi: 10.1177/0898264310371980. Epub 2010 Jul 26.

PMID:
20660638
29.

Structural equation modeling of health-related quality-of-life data illustrates the measurement and conceptual perspectives on response shift.

King-Kallimanis BL, Oort FJ, Visser MR, Sprangers MA.

J Clin Epidemiol. 2009 Nov;62(11):1157-64. doi: 10.1016/j.jclinepi.2009.04.004.

PMID:
19595574
30.

Screening and brief intervention for substance misuse among older adults: the Florida BRITE project.

Schonfeld L, King-Kallimanis BL, Duchene DM, Etheridge RL, Herrera JR, Barry KL, Lynn N.

Am J Public Health. 2010 Jan;100(1):108-14. doi: 10.2105/AJPH.2008.149534.

Supplemental Content

Loading ...
Support Center